Month: May 2022

A new androgen biosynthesis inhibitor drug improved progression-free survival in prostate cancer but did not improve overall survival compared to current therapies.

A new, smart pacemaker is integrated into a coordinated network of four soft, flexible, wireless, wearable sensors and control units placed around the upper body.

The membrane-bound form of the ACE2 protein is the essential receptor for enabling COVID-19 infectivity, according to a Northwestern Medicine study.

Feinberg’s Medical Faculty Council recently honored the recipients of the 2022 Mentor of the Year award at a virtual mentoring workshop.

The Cancer Immunology and Immunotherapy Initiative at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University is bringing together Feinberg investigators who study immunotherapy to increase collaboration and accelerate high-impact immunotherapy research.

Investigators have discovered the mechanisms underlying a T-cell receptor’s immunosuppressive function, findings that may improve the development of precision therapeutics for chronic disease, including cancer.

Most non-hospitalized COVID-19 “long-haulers” at the Northwestern Medicine Neuro COVID-19 Clinic continued to experience symptoms including brain fog, dizziness and fatigue 15 months after disease onset, according to a new study.

Feinberg honored the MD Class of 2022 during the medical school’s 163rd commencement ceremony in the Aon Grand Ballroom at Navy Pier, held in person for the first time since 2019.

William Gradishar, MD, chief of Hematology and Oncology in the Department of Medicine and deputy director of the clinical network of the Lurie Cancer Center, has received the 2022 Rodger Winn Award from the National Comprehensive Cancer Network.

Dozens of faculty members and fourth-year medical students were recognized for their scholarly and clinical excellence at Feinberg’s Honors Day, held May 20.